Immuron Limited Profit Margin

The latest profit margin for IMRN is -59.97% as of June 2026. That compares with -105.94% in the prior-year period — up 43.4% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Immuron Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMRN's profit margin moved from -105.94% to -59.97% — a 43.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immuron Limited's valuation or profitability profile.

Against Healthcare companies, IMRN currently prints -59.97% for profit margin, while the sector average sits near 21.34%. That is roughly 381.1% below the sector mean. Large gaps often invite a closer look at Immuron Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Immuron Limited converts resources into returns. At -59.97%, IMRN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -105.94% in the prior-year period — up 43.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IMRN's profit margin (-59.97%), review year-over-year change from -105.94%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.